ArticleLeukemia2024
Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma.
Chenggong Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this paperpooled itcites it
ArticleLeukemia2024
Chenggong Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.